Browse Studies — Arctuva

A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension

This study will evaluate whether participants with serious lung diseases such as idiopathic pulmonary fibrosis, sarcoidosis, and pulmonary hypertension who use…

Idiopathic Pulmonary Fibrosis (IPF)Sarcoidosis LungPulmonary Hypertension+1 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.